Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.68 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | BCR | P11274 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.40 |
| ▸ | CCND1 | P24385 | 1/20 | 0.40 |
| ▸ | JUN | P05412 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5533754 | 1.00 | TRPA1 (0.68) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL27992 | 0.82 | TRPA1 (1.00) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL3464547 | 0.82 | TRPA1 (1.00) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL27991 | 0.82 | TRPA1 (1.00) | TRPA1ABL1ABCB1BCRNFKB1 | |
| Benzene SCHEMBL27382741 | 0.82 | TRPA1 (1.00) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL30218372 | 0.82 | TRPA1 (1.00) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL28990965 | 0.81 | TRIM24 (0.42) | TRPA1NFKB1CA1CA2CA4 | |
| Formaldehyde SCHEMBL20525513 | 0.81 | TRPA1 (0.88) | TRPA1ABL1ABCB1BCRNFKB1 | |
| Formaldehyde SCHEMBL27679663 | 0.81 | TRPA1 (0.88) | TRPA1ABL1ABCB1BCRNFKB1 | |
| SCHEMBL9419814 | 0.80 | TRPA1 (0.95) | TRPA1ABL1ABCB1BCRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015840-A1 | Use of an alkyl ether of hydroxystilbene for the treatment of dry skin | L'OREAL (FR) | 2007-01-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015840-A1 | Use of an alkyl ether of hydroxystilbene for the treatment of dry skin | CYP8B1, HSD17B11, HSD17B1 | TRPA1 876/4885ABL1 4538/4885ABCB1 4308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.